TRADES
Latest Trades
115
results found
FUND
DATE
ACTION
TICKER
COMPANY
SHARES
% of ETF
ARKG 15 Sep 2022 Sell CGEN COMPUGEN LTD 31 0.0000
ARKK 15 Sep 2022 Sell CGEN COMPUGEN LTD 1 0.0000
ARKG 14 Sep 2022 Sell CGEN COMPUGEN LTD 45,377 0.0017
ARKK 14 Sep 2022 Sell CGEN COMPUGEN LTD 126,283 0.0016
ARKG 13 Sep 2022 Sell CGEN COMPUGEN LTD 66,073 0.0024
ARKK 13 Sep 2022 Sell CGEN COMPUGEN LTD 196,027 0.0023
ARKG 12 Sep 2022 Sell CGEN COMPUGEN LTD 177,075 0.0066
ARKK 12 Sep 2022 Sell CGEN COMPUGEN LTD 525,625 0.0064
ARKG 8 Sep 2022 Sell CGEN COMPUGEN LTD 165,437 0.0063
ARKK 8 Sep 2022 Sell CGEN COMPUGEN LTD 325,010 0.0042
ARKG 7 Sep 2022 Sell CGEN COMPUGEN LTD 194,342 0.0080
ARKK 7 Sep 2022 Sell CGEN COMPUGEN LTD 387,704 0.0053
ARKG 6 Sep 2022 Sell CGEN COMPUGEN LTD 4,813 0.0002
ARKK 6 Sep 2022 Sell CGEN COMPUGEN LTD 9,699 0.0001
ARKG 2 Sep 2022 Sell CGEN COMPUGEN LTD 12,624 0.0005
ARKK 2 Sep 2022 Sell CGEN COMPUGEN LTD 25,610 0.0004
ARKG 1 Sep 2022 Sell CGEN COMPUGEN LTD 23,613 0.0010
ARKK 1 Sep 2022 Sell CGEN COMPUGEN LTD 47,741 0.0007
ARKG 30 Aug 2022 Sell CGEN COMPUGEN LTD 4,084 0.0002
ARKK 30 Aug 2022 Sell CGEN COMPUGEN LTD 8,138 0.0001
ARKG 29 Aug 2022 Sell CGEN COMPUGEN LTD 22,389 0.0010
ARKK 29 Aug 2022 Sell CGEN COMPUGEN LTD 45,832 0.0007
ARKG 25 Aug 2022 Sell CGEN COMPUGEN LTD 21,434 0.0010
ARKK 25 Aug 2022 Sell CGEN COMPUGEN LTD 44,076 0.0007
ARKG 24 Aug 2022 Sell CGEN COMPUGEN LTD 17,952 0.0008
ARKK 24 Aug 2022 Sell CGEN COMPUGEN LTD 36,390 0.0006
ARKG 23 Aug 2022 Sell CGEN COMPUGEN LTD 11,782 0.0006
ARKK 23 Aug 2022 Sell CGEN COMPUGEN LTD 22,921 0.0004
ARKG 18 Aug 2022 Sell CGEN COMPUGEN LTD 324,689 0.0155
ARKK 18 Aug 2022 Sell CGEN COMPUGEN LTD 643,118 0.0097
ARKG 16 Aug 2022 Sell CGEN COMPUGEN LTD 134,342 0.0897
ARKK 16 Aug 2022 Sell CGEN COMPUGEN LTD 266,517 0.0368
ARKG 15 Aug 2022 Sell CGEN COMPUGEN LTD 316,735 0.0146
ARKK 15 Aug 2022 Sell CGEN COMPUGEN LTD 629,007 0.0092
ARKG 12 Aug 2022 Sell CGEN COMPUGEN LTD 369,531 0.0180
ARKK 12 Aug 2022 Sell CGEN COMPUGEN LTD 738,733 0.0112
ARKG 11 Aug 2022 Sell CGEN COMPUGEN LTD 434,497 0.0211
ARKK 11 Aug 2022 Sell CGEN COMPUGEN LTD 884,534 0.0132
ARKG 10 Aug 2022 Sell CGEN COMPUGEN LTD 84,896 0.0043
ARKK 10 Aug 2022 Sell CGEN COMPUGEN LTD 173,745 0.0027
ARKG 9 Aug 2022 Sell CGEN COMPUGEN LTD 31,857 0.0015
ARKK 9 Aug 2022 Sell CGEN COMPUGEN LTD 65,721 0.0009
ARKG 8 Aug 2022 Sell CGEN COMPUGEN LTD 22,341 0.0011
ARKK 8 Aug 2022 Sell CGEN COMPUGEN LTD 46,034 0.0007
ARKG 4 Aug 2022 Sell CGEN COMPUGEN LTD 35,594 0.0019
ARKK 4 Aug 2022 Sell CGEN COMPUGEN LTD 75,871 0.0012
ARKG 3 Aug 2022 Sell CGEN COMPUGEN LTD 74,934 0.0043
ARKK 3 Aug 2022 Sell CGEN COMPUGEN LTD 159,841 0.0027
ARKG 2 Aug 2022 Sell CGEN COMPUGEN LTD 16,561 0.0010
ARKK 2 Aug 2022 Sell CGEN COMPUGEN LTD 35,483 0.0006
ARKG 1 Aug 2022 Sell CGEN COMPUGEN LTD 13,067 0.0008
ARKK 1 Aug 2022 Sell CGEN COMPUGEN LTD 28,083 0.0005
ARKG 28 Jul 2022 Sell CGEN COMPUGEN LTD 7,292 0.0004
ARKK 28 Jul 2022 Sell CGEN COMPUGEN LTD 15,677 0.0003
ARKG 27 Jul 2022 Sell CGEN COMPUGEN LTD 38,038 0.0023
ARKK 27 Jul 2022 Sell CGEN COMPUGEN LTD 81,039 0.0015
ARKG 22 Jul 2022 Sell CGEN COMPUGEN LTD 31,270 0.0021
ARKK 22 Jul 2022 Sell CGEN COMPUGEN LTD 65,729 0.0013
ARKG 20 Jul 2022 Sell CGEN COMPUGEN LTD 130,504 0.0087
ARKK 20 Jul 2022 Sell CGEN COMPUGEN LTD 271,737 0.0056
ARKG 19 Jul 2022 Sell CGEN COMPUGEN LTD 53,303 0.0037
ARKK 19 Jul 2022 Sell CGEN COMPUGEN LTD 110,801 0.0024
ARKG 18 Jul 2022 Sell CGEN COMPUGEN LTD 13,245 0.0009
ARKK 18 Jul 2022 Sell CGEN COMPUGEN LTD 27,408 0.0006
ARKG 13 Jul 2022 Sell CGEN COMPUGEN LTD 71,073 0.0049
ARKK 13 Jul 2022 Sell CGEN COMPUGEN LTD 146,975 0.0031
ARKG 12 Jul 2022 Sell CGEN COMPUGEN LTD 28,463 0.0020
ARKK 12 Jul 2022 Sell CGEN COMPUGEN LTD 59,582 0.0013
ARKG 11 Jul 2022 Sell CGEN COMPUGEN LTD 62,697 0.0045
ARKK 11 Jul 2022 Sell CGEN COMPUGEN LTD 131,205 0.0029
ARKK 26 Jan 2022 Buy CGEN COMPUGEN LTD 7,400 0.0002
ARKK 25 Jan 2022 Buy CGEN COMPUGEN LTD 32,210 0.0009
ARKK 24 Jan 2022 Buy CGEN COMPUGEN LTD 102,100 0.0029
ARKK 18 Jan 2022 Buy CGEN COMPUGEN LTD 27,391 0.0008
ARKK 14 Jan 2022 Buy CGEN COMPUGEN LTD 51,100 0.0014
ARKK 13 Jan 2022 Buy CGEN COMPUGEN LTD 56,736 0.0015
ARKK 12 Jan 2022 Buy CGEN COMPUGEN LTD 55,641 0.0016
ARKK 7 Jan 2022 Buy CGEN COMPUGEN LTD 28,281 0.0008
ARKK 6 Jan 2022 Buy CGEN COMPUGEN LTD 89,164 0.0025
ARKG 5 Jan 2022 Buy CGEN COMPUGEN LTD 71,500 0.0061
ARKG 4 Jan 2022 Buy CGEN COMPUGEN LTD 23,216 0.0020
ARKG 3 Jan 2022 Buy CGEN COMPUGEN LTD 14,413 0.0012
ARKG 31 Dec 2021 Buy CGEN COMPUGEN LTD 36,600 0.0031
ARKG 30 Dec 2021 Buy CGEN COMPUGEN LTD 66,398 0.0058
ARKK 27 Dec 2021 Sell CGEN COMPUGEN LTD 12,900 0.0003
ARKK 25 Jan 2021 Sell CGEN COMPUGEN LTD 54,768 0.0029
ARKK 22 Jan 2021 Sell CGEN COMPUGEN LTD 56,200 0.0029
ARKK 21 Jan 2021 Sell CGEN COMPUGEN LTD 12,750 0.0007
ARKK 20 Jan 2021 Sell CGEN COMPUGEN LTD 37,707 0.0022
ARKK 19 Jan 2021 Sell CGEN COMPUGEN LTD 143,018 0.0100
ARKK 15 Jan 2021 Sell CGEN COMPUGEN LTD 10,567 0.0007
ARKK 14 Jan 2021 Sell CGEN COMPUGEN LTD 145,699 0.0100
ARKG 13 Jan 2021 Sell CGEN COMPUGEN LTD 200 0.0000
ARKK 13 Jan 2021 Sell CGEN COMPUGEN LTD 111,100 0.0100
ARKK 12 Jan 2021 Sell CGEN COMPUGEN LTD 58,241 0.0035
ARKK 11 Jan 2021 Sell CGEN COMPUGEN LTD 8,173 0.0005
ARKK 8 Jan 2021 Sell CGEN COMPUGEN LTD 113,200 0.0075
ARKK 7 Jan 2021 Sell CGEN COMPUGEN LTD 70,897 0.0047
ARKG 16 Nov 2020 Sell CGEN COMPUGEN LTD 175,694 0.0710
ARKG 13 Nov 2020 Sell CGEN COMPUGEN LTD 16,084 0.0065
Latest Blogs
ARK by Cathie Wood is still suffering a year after its apex.

Cathie Wood's flagship exchange-traded fund hit an all-time high in February of this year. Her preferred disruptive-tech chasing strategy may still be in for a lot of suffering after a year and a 53 percent fall.

After a dramatic decline last month, the ARK Innovation ETF (ticker: ARKK) has steadied off - it's practically flat in February – but the headwinds surrounding its speculative growth picks are just becoming more vital. Many businesses that thrived during the pandemic are being hammered by the economic reopening, not only because yields are rising as investors prepare for the US Federal Reserve to raise interest rates, which is terrible news for unprofitable businesses, but also because the economic reopening is hammering many of the businesses that thrived during the pandemic.

Roku, Teladoc, and Zoom, all winners in the work-from-home era, have had their stock prices plummet by as much as 74% in the past year.

Short bets against ARK, according to IHS Markit data, hit a fresh high of 11.4 percent of outstanding shares this week. The Tuttle Capital Short Innovation ETF (SARK), which beats the ARK, now has assets worth more than $US300 million ($416 million).

"Those equities are supported by speculation, and speculation pays less well when the Fed raises rates," said Brent Schutte, chief investment strategist at Northwestern Mutual Wealth Management Co. "Much of what's happening in the market reminds me of what happened in the late 1990s when market segments were bid up to levels based on future assumptions."

Because its price chart resembles that of the Nasdaq index of technology businesses from more than two decades ago, analogies to that period and the dot-com implosion that followed are becoming more common in discussions of ARK.

"Today marks the 253rd trading day from ARK's all-time high," Jessica Rabe, co-founder of DataTrek Research, wrote in a Tuesday note, "while the Nasdaq was down 60% from its dot-com bubble top on the same day in 2001."

"If 2000/2001 analog holds, we should see ARK continuing to fall over the following three weeks. The Nasdaq dropped 18.7% in the next 16 trading days "recent."

Net flows are positive.

The better news for investors and Ms. Wood is that there may be some immediate respite. The Nasdaq rose 41% in six weeks in 2001 before falling.

The ARK Investment Management did not respond to a request for comment.

Most of ARK's $US15 billion asset loss has been attributed to bad performance, a plus for the company. Since the fund achieved an intraday high of $US159.70 a year ago this week, investors have withdrawn only around $US465 million, and ARK's net flows this year are positive despite a more than 20% drop.

This exceptional loyalty prevents a worsening situation and allows Wood's approach to recovering. The star fund manager has consistently emphasized that her funds have a five-year investment horizon and that she believes in many good options.

Mr. Schutte, on the other hand, says the drop is understandable because several of the company's biggest bets, such as Teladoc and Zoom, are becoming less significant as COVID-19 approaches.

"During the pandemic, there were a lot of questions about what would happen to society and how we'd go about our lives," he added.

"You drew in new investors who wanted to know "what are the upcoming themes I should invest in?" I believe you got a washout of it as well."

On Friday, Cathie Wood sold $148.9 million worth of Palantir stock, halving her exposure.

Ark Investment Management, run by Cathie Wood, sold more Palantir Technologies Inc PLTR -6.39 percent shares on Friday, cutting its stake in the Peter Thiel-backed company.

According to Friday's closing price, the famous investment management firm sold 13.5 million shares of the big data company, valued at $148.9 million.

Palantir's stock fell 6.4 percent to $11.02 per share on Friday. The stock has lost 16% of its value in the last week.

Before Friday's trade, Ark Invest held 25.53 million shares in Palantir, suggesting that the famous stock picker had trimmed over 52 percent of its total keeping a day later.

After the business disclosed lower-than-expected fourth-quarter earnings before the market opened on Thursday, Ark Invest, located in St. Petersburg, California, dumped shares in Palantir for the second time.

The software firm, well-known for its work with government organizations, posted earnings of 2 cents per share, falling short of the analyst consensus of 4 cents. The company recorded quarterly revenues of $432.87 million, higher than the $417.69 million predicted by analysts.

Palantir's stock had been sold for 4.77 million shares by the investment firm the day before.

All six of Ark Invest's active exchange-traded funds own Palantir stock, including the flagship Ark Innovation ETF ARKK -4.88 percent.

Before the recent sell-off, Ark Invest had been stockpiling Palantir shares for months.

Cathie Wood appeared on television to defend her ARK funds' dismal performance. It didn't go quite as planned.

The Ark Innovation ETF (ARKK), Cathie Wood's flagship fund, is down 30% year to date and more volatile than almost any other fund on the market. On CNBC's Halftime Report, Wood jumped at the chance to defend the fund and its deflated price, which is currently $68.80, down from $155 a year ago.

"We've seen a significant decline," Wood said, adding, "We feel innovation is at bargain basement zone." Even though her ETF was underperforming, she emphasized that her companies were still "very inexpensive" and that the current fund loss was temporary. When the call's 40 free minutes were finished, Zoom gave her an extra 10 minutes to complete the interview.

Having Zoom check to see whether she was "running out of time?" Wood, who has been aggressively buying up shares in Zoom and other IT firms that have fallen from their pandemic highs, was unhappy. Zoom, like Wood's other significant tech holdings, Teladoc Health, Roku, and Roblox, is down 20% to 40% year to date as investors worry about rising interest and inflation rates.

However, a significant chunk of the interview was devoted to a personal assault on Cathie Wood, who was named the most excellent stock picker in 2020 by Bloomberg's then-Editor-in-Chief Matthew Winkler after correctly forecasting that Tesla will one day be valued at more than $1 trillion.

Wood bluntly ignored Tuttle Capital Management's Short Innovation ETF (SARK), which tracks the inverse performance of ARKK using swaps contracts for the sole purpose of betting against Cathie Wood's selections. "They're not conducting any research." She explained, "All they're doing is shorting innovation."

Of course, SARK is betting against Cathie Woods, not on innovation. "Well, we stand for invention," Wood responded. The SARK ETF has gained 55 percent since its debut, whereas the ARKK ETF has declined by 42 percent.

Tuttle Capital Management CEO Matthew Tuttle chimed in on the SARK ETF, calling it a "tool" for investors. According to SARK, "to convey a negative view of the market, innovative enterprises, the current rising rate environment, or a [specific] portfolio manager if they wish." "It's un-American not to have options in the marketplace," Tuttle told Insider on Thursday.

In any event, Wood is making progress. Her main concern currently is bearish calls on her ETF. "Our major concern is that our investors convert temporary losses into long-term losses," Wood continued.